 39 PM / Updated 11 minutes ago BRIEF-Cardiome Announces Expanded Label For Aggrastat In China Reuters Staff 1 Min Read 
Jan 23 (Reuters) - Cardiome Pharma Corp: 
* CARDIOME ANNOUNCES EXPANDED LABEL FOR AGGRASTATÂ® IN CHINA INCLUDING NEW STEMI INDICATION AND HIGH DOSE BOLUS REGIMEN 
* CARDIOME PHARMA - AGGRASTAT EXPANDED LABEL NOW INCLUDE PATIENTS WITH STEMI WHO ARE INTENDED FOR PRIMARY PERCUTANEOUS CORONARY INTERVENTION 
* CARDIOME PHARMA - CHINESE CENTER FOR DRUG EVALUATION ALSO APPROVED AGGRASTAT HIGH DOSE BOLUS REGIMEN TO BE USED ON BOTH INDICATED PATIENT POPULATIONS IN STUDY Source text for Eikon: Further company coverage: